On May 28, 2021, Massachusetts Governor Charlie Baker signed into law an act requiring eligible Massachusetts employers to provide emergency paid sick leave to employees who are unable to work for COVID-19–related reasons. On September 29, 2021, Governor Baker approved an extension of the law, titled “An Act Providing for Massachusetts COVID-19 Emergency Paid Sick Leave,” and increased its funding.
The act was set to remain in effect until April 1, 2022, or until the exhaustion of $100 million in program funds, whichever came first. On February 28, 2022, the Commonwealth announced that the act will end on March 15, 2022.
The act requires an employer to provide an employee with up to forty hours of paid leave (a maximum benefit of $850 per week, reimbursable to the employer from the Commonwealth’s COVID-19 Emergency Paid Sick Leave Fund) when the employee:
- needs to “self-isolate and care for [himself or herself] because of the employee’s COVID-19 diagnosis”;
- needs to “care for a family member who is self-isolating due to a COVID-19 diagnosis”;
- needs to obtain a “medical diagnosis, care or treatment for COVID-19 symptoms”;
- needs to “care for a family member” seeking “medical diagnosis, care or treatment for COVID-19 symptoms”;
- is unable to telework due to a COVID-19 diagnosis “and the symptoms inhibit the ability of the employee to telework”;
- uses the time to obtain a COVID-19 vaccination or recover from illness related to the COVID-19 vaccination; or
- is subject to a quarantine order or similar determination, or such an order or determination applies to the employee’s family member, due to COVID-19 exposure or symptoms, “regardless of whether” the employee or the employee’s “family member has been diagnosed with COVID-19.”
Key Updates and Developments
Under the act, the Executive Office for Administration and Finance had the authorization to end the program with fifteen days’ notice when $85 million worth of applications for reimbursement had been submitted. As of February 28, 2022, $85 million in applications had been submitted.
The act will now expire on March 15, 2022, as the exhaustion of $85 million in funds has been met. The act requires that employers continue to offer leave to eligible employees through March 15, 2022.
Employers may still submit applications for reimbursement after March 15, 2022, for qualifying leaves taken between May 28, 2021, and March 15, 2022. Applications for reimbursement must be submitted by April 29, 2022.
Ogletree Deakins will continue to monitor and report on guidance issued with respect to the act and will post updates on the Massachusetts blog and in the firm’s Coronavirus (COVID-19) Resource Center as additional information becomes available. Important information for employers is also available via the firm’s webinar and podcast programs.
